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Abstract  
 
Objective The aim of this study was to detect the arginase Ι (ARG I) enzyme in asthma patients, clarify its role, in 
addition to examining the relationship of this enzyme with bronchial asthma. 
Methods: 
Blood samples were collected from 100 patients from Department of Medicine in Rizgary Hospital in Erbil City, in 
addition to intact 100 volunteers; the introduced questionnaire was filled out on the basis of type-induced asthma, 
duration of the disease, age of the patients, gender, family history, and allergy condition, Serum was separated to 
perform Enzyme-linked immunosorbent assay (ELISA) in Medical Research Center to examine the association of 
ARGΙ with bronchial asthma. By ARG activity we can measure the conversion of arginine to ornithine and urea. By 
using a quantitative colorimetric assay at 490 nm, employing a QuantiChrom arginase assay kit (Bioassay Syst ems).  
Results: Our results depicted the association between ARGΙ and bronchial asthma: based on their age, significant 
elevation of serum arginase level was observed in the patients with ≥81 years old, which mean value (100.16±19.77c), p 
value (0.000); also the duration of asthma ≥20 years (82.48±38.81c) ,p value (0.01) were remarkably affected; this 
significance was found in those with types of induced asthma and with allergy condition.  But non- significant 
difference in frequency of abnormal serum arginase level was observed in those patients that have family  history of 
asthma disease and gender of the patients. This finding demonstrated a remarkable association of ARG Ι in the 
development of asthma at p > 0.05. 
 
Conclusion: The ELISA results indicated that the ARG I and bronchial asthma are remarkably correlated. Patients with 
asthmatic symptoms have the high level of ARG Ι (> 40 IU/L). 
                       
1- Introduction 
Asthma is chronic lung disease affects 300 million people worldwide [1]. Allergic asthma is a disease of 
airway inflammation and hyperresponsiveness. Asthma occur by activating IgE, receptor which is bearing mast cells 
and basophils, and triggering factors for this, is inhalation of allegen when it bind to complementary IgE. And this is 
lead to lung  infiltration by eosinophils, neutrophils, then activated (M2) macrophages and (TH2) lymphocytes, which 
are inflammatory triggers and all these increase mucus production, which is leading to mucosal edema, smooth-muscle 
hyperresponsiveness, and airway hyperresponsiveness (AHR) due to exposure to e.g. histamine and methacholine [2], 
[3]. 
Arginase (ARG) is an essential enzyme that can be detected in mammals and plants. Particularly in humans, 
being a partaker in the last phase of urine cycle, ARG accelerates conversion of arginine to ornithine and urea. 
Moreover, ARG level remarkably escalates in those whose body suffers from asthmatic symptoms [4].   
The ARG according to Vercelli and Meurs has rule in asthma through different mechanisms which is leading 
to remodeling of airway through polyamine and proline synthesis by inhibiting  nitric oxide, (NO) synthesis, reduction 
of arginine bioavailability, and increasing  ornithine production [5], [6]. 
238 
Journal of University of Babylon for Pure and Applied Sciences,Vol.(27), No.(2): 2019 
 
Cederbaum et al. (2004) showed that the enzyme has two types; ARGΙ and ARG II [7]. Also, both are, 
"encoded by a different genes"[8].Furthermore “ARG Ι may be present inside the cytoplasm and expressed in the liver 
as a part of the urea cycle. ARG Ι also present in the airway and lung, which they do not have urea cycle [7], Some 
studies reported that increase in the level of arginine is an autosomal recessive disease which is caused by a defect in 
the ARGΙ enzyme [9].  
There is expanding proof that ARG is moreover imperative in the pathophysiology of human asthma [10]. 
Morris et al (2004), and other researchers reported that decreasing  ARG activity and increasing   L-arginine 
concentrations will occur in some patients which have improvement of asthma symptoms [11]. 
Moreover, immunohistochemical studies about expanded ARG Ι protein articulation in the aviation route 
epithelium and aviation route smooth muscle layer of smoking asthmatics contrasted with nonsmoking patients, which 
may be initiated by nicotine [12]. 
With respect to the different opinion about the importance of ARGΙ in asthma, the aim of this research was to 
detect ARG Ι enzyme in asthma patients, clarify its role, in addition to examining the relationship of this enzyme with 
bronchial asthma.  
 
2- Materials and Methods 
 
2 -1 Participants   
  We performed this study on one hundred subjects with clinical signs of asthma (patients group), and one 
hundred subjects without clinical signs of asthma (control group), during September 2017 up to May 2018. The ages of 
the patients ranged from 40-103 years and categorized into three groups:  ≤ 60, 61-80, and ≥ 81.  
All work involving human subjects selected from patients attending the Department of Medicine in Rizgary 
Hospital, in addition to intact volunteers; the introduced questionnaire was filled out on the basis of type-induced 
asthma, duration of the disease, age of the patients, gender, family  history of allergy, and allergy condition, 
consensually, of course: 79(79%) out of 100 asthma subjects had an abnormal level of ARGΙ, and 21(21%) had a 
normal level. The ethics approval of this study was given by the Ethics Committee of Medical Research Center /Hawler 
Medical University. 
 
2-2 Enzyme-linked immunosorbent assay (ELISA)  
ELISA (ELx800-BioTeK80, U.S.A) in Medical research center was performed for all subjects to examine the 
association of ARGΙ with bronchial asthma. Two hundred blood samples were taken from asthma and non-asthma 
participants. Serum was separated to perform ELISA.  By ARG activity, we can measure the conversion of arginine to 
ornithine and urea, by using a quantitative colorimetric assay at 490 nm, employing a QuantiChrom arginase assay kit 
(Bioassay Systems). (40 μl) of serum sample was combined with 10 μl of the substrate buffer, then added to a 96-well 
flat-bottomed plate with the appropriate blank controls and 50 μl 1mM Urea reagent (supplied with the kit)  then added 
to wells to stop the reaction of arginase and incubated at RT for two hours. Then measuring the absorbance at 490 nm 
and enzyme activity (in IU), calculated according to the kit instructions. 
     The test result was considered negative (normal value), when the arginase level was ≤40 IU and positive (abnormal 
level) at > 40 IU.  
 
2-3 Statistical Analysis 
Statistical Package for Social Science (SPSS) software version 19 was used for statistical analysis. 
Qualitative parameters were compared between groups by Pearson Chi-square, while quantitative variables were 
expressed as the mean ± standard deviation (SD). Differences were considered statistically significant at p ˂0.05. 
                                                                                                                                                                                  
4-Results and Discussion 
Study participants were classified into two groups: asthma (n=100) and non-asthma (n=100) subjects. Table 
(1) depicts the frequencies of normal and abnormal serum ARGs level in healthy and patient groups; in which normal 
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Table 1. The frequency of normal and abnormal serum arginase level in the healthy person and patient groups. 
 






Normal level 100 (100%) 21 (21%) 
0.000 
Abnormal level 0 (0%) 79 (79%) 
 
According to table (2), the mean age of the study population was 65.73±15, the control mean age was 
39.9±10.59, and the male to female ratio was 7/93. This table summarizes the characteristics of topics by many clinical 
parameters: significant differences in age, duration of the disease and serum ARG level were observed between control 
and patient groups. Gender, types of induced asthma, family history and allergy condition were significantly different  
between groups. Mean value of arginase was 25.93±7.01 and 61.28±33.93 for healthy donor and asthmatic patients, 
respectively.  
 
Table 2. Comparison of clinical history between the healthy persons and asthma patients. 
 





Age (Mean±SD) 39.9±10.59 65.73±15.08 0.041 
Arginase level  IU/L (Mean±SD) 25.93±7.01 61.28±33.93 0.000 
Duration year (Mean±SD) 0.00±0.00 10.01±10.65 0.000 
Gender (No.) 
Male 60 7 
0.000 



















Adulthood induced (No.) 
Yes 0 98 
0.000 
No 100 2 
Exercise -induced (No.) 
Yes 0 93 
0.000 
No 100 7 
Occupational induced (No.) 
Yes 0 68 
0.000 
No 100 32 
Family history (No.) 
Yes 0 39 
0.000 
No 100 61 
Allergy (No.) 
Yes 0 53 
0.000 
No 100 47 
P value <0.05: S ignificant difference     
 
As table (3) shows, the age of the patients ranged from 40-103years and categorized into three groups: 23% 
of asthma patients which have age ≤ 60 years have a mean of ARG level 53.64±24.26ab; 69% of asthma patients with 
61-80 years old have a mean of ARG level 59.45±32.46b, and;8% of them which have ≥ 81years old have mean of 
ARG level 100.16±19.77c.  Significant elevation of serum ARG level was found in asthma patients with age group ≥81 
compared with other groups (p=0.000).  Interestingly, in our study, the patients who were ≥ 81years showed the highes t  
mean of ARG level (100.16±19.77), if compared with other group ages. We proposed that the age of patients was 
related to asthmatic subjects, and can be attributed to increases in ARG Ι expression and activity. The previous study 
showed that bronchial asthma is a significant health issue: 5% to 10% of people at different ages suffer from such 
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Table 3. Serum level of arginase in asthma patients according to age groups. 
 







Arginase level IU/L (Mean±SD) 53.64±24.26ab 59.45±32.46b 100.16±19.77c 0.000 
Different letters: mean significant differences, P value <0.05: S ignificant difference 
 
Table (4) depicts the duration-based asthma disease.  The mean of ARG level was 61.35±38.15ab for 46% of 
patients who were suffering from asthma for 9 years and above. For 38% of asthma patients who were living with the 
disease for 10 to 19 years, had the 52.28±0.53b mean of ARG level. And 16% of asthma patients with ≥20 disease 
interval scored 82.48±38.81c.  Significant elevation of serum ARG level was observed in patients suffering asthma for 
more than 20 years (p=0.01). The results revealed that the duration of disease was related to the level of ARG Ι. 
Patients with symptoms of asthma (≤ 9 and ≥20 years) have abnormal levels of ARG Ι, but the highest ARG level 
(82.48±38.81c) was observed in 16% of asthma patients who have the disease for more than 20 years.  Moreover, the 
duration of disease is one of the important factors in increasing the activity of ARG Ι and decreasing L-arginine 
concentration. In a study done by North et al. It became evident that the increase of ARG I levels in chronic asthma is 
more significant, compared with acute cases [13]. 
 
Table 4. Serum level of arginase in asthma patients according to disease duration . 
 







Arginase level IU/L (Mean±SD) 61.35±38.15ab 52.28±20.53b 82.48±38.81c 0.01 
Different letters: mean significant differences, P value <0.05: S ignificant difference 
 
As table (5) shows, no significant correlation was found between ARGI activity and these variables (gender 
and family history), except for types of induced asthma and allergy asthma, both which were significant. Based on the 
results of this study, seventy-eight patients with exercise-induced asthma have high levels of arginase, and fifteen 
patients have a normal level of the enzyme.  According to our knowledge, we could find that exercise-induced asthma 
was significantly associated with ARG activity. [16] ,in Japan reported that the mean value of ARG activity of eleven 
employees, who were daily trained for a week, was 6.3±0.7. For fifty -three of workers exercised not on a daily basis, 
the mean value of ARG activity was 4.8±0.3. One hundred nineteen workers with no exercise had their mean value of 
ARG activity touched 3.9±0.2. It means that the group with daily training has highest ARG level compared with other 
groups. 
Regarding the study findings, the significant prevalence of abnormal serum ARG level was found in seventy -
nine patients with adulthood induced asthma, who were recruited for this study at Rizgary Teaching Hospital/ Medicine 
department in Erbil. Morris et al. showed that from twenty-six adult patients that have history of asthma at different 
stages of exacerbation there is a high ARG activity if compared to normal control subjects without asthma (1.6 ± 0.8 
versus 0.5 ± 0.3 μmol/ml/hour, asthma versus control, p < 0.0001) and low level of  arginine, compared to normal 
control subjects without asthma (45 ± 22 versus 94 ± 29 μM, p < 0.0001) [11]. 
In this study, occupations considered one of the causes of asthma: seventy-four patients were workers who 
inflicted occupational asthma by breathing in chemical fumes, dust, gases, or other substances on the job, or could 
result from exposure to a substance which they’re sensitive to. The frequency of high level of ARG (which is more than 
40 IU/L) found in the seventy-four patients was statistically significant (p=0.000).  The previous studies articulated that 
surrounding particles and ozone layer are the most common causes of urban air pollution, both which are causes of 
environmental exposures in murine models of airways inflammation due to arginase I up-regulation [17]. 
The results of our study were strongly related to family history of asthma. Forty -one patients out of 54 had an 
abnormal level of ARG, while the rest 13 had normal levels (P =0.414). Our results demonstrated that a family history 
of asthma is a significant risk factor for asthma and familial risk assessments also help recognizing an individual’s 
highest risk to get asthma. [18]reported that the results of  population-based cohort  study indicate that  the  asthma 
during the first 27 years of life are usually strongly related to family history of asthma. The results indicate that children 
of asthmatic mother will develop asthma earlier than those with asthmatic father, which is reflected in the effect 
estimates. Otherwise study of [19] reported that the familiarly asthma both maternal and paternal asthma had more risk 
of adult –onset asthma. In the present study, fifty-three patients with asthma have allergies ,and this is called allergic asthma 
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which can be triggered by pet dander, pollen, dust and other allergy stimulators, and forty-seven patients with non-
allergic asthma can be spread by stress, medication, air temperature, smoke, and infections of the airway . It means that 
asthma can be associated with either an allergic or non-allergic conditions. Forty-nine of fifty-three patients with allergy 
had an abnormal level of arginase. Consistent with the result of Maarsingh et al. [20].  In this study, we revealed the 
association of arginase I in the development of asthma. 
 
Table 5. The frequency of clinical history parameters among asthma patients according to the normal and 
abnormal serum level of arginase. 
 
 







Male (7) 1  6  
0.546 



















Adulthood induced (No.)  
Yes (98) 19  79  
0.042 
No (2) 2  0  
Exercise induced (No.) 
Yes (93) 15 78 
0.000 
No (7) 6  1  
Occupational induced (No.) 
Yes (68) 5  63  
0.000 
No (32) 16 16  
Family history (No.) 
Yes (54) 13 41  
0.414 
No (46) 8  38  
Allergy (No.) 
Yes (53) 4 49  
0.000 
No (47) 17 30  
P value ≥0.05: Non-S ignificant difference, P value <0.05: S ignificant difference  
 
5-Conclusion 
Our findings provide evidence for the key role of ARG I activity in the asthma disease. Therefore, this 
enzyme might serve as a useful biological marker in asthma disease.  
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ةصلاخلا 
:فدهلا  زنيجرا ميزنإ نع فشكلا وه ةساردلا هذه نم فدهلاI  .يبصقلا وبرلاب هتقلاع ةسارد و وبرلاب نيباصملا ىضرم يف هرودو 
 :قرطلاو داوملا نم مدلا تانيع عمج مت100  و يميلعتلا يراكزر ىفشتسم يف ةينطابلا مسق اولخدا نيذللا وبرلا ضرمب نيباصم ىضرم100  نم ًاصخش
نلا وبرلا ضرم ساسأ ىلع نايبتسلاا ءلم مت ثيح .ةنراقملا ةعومجمك نمزم وأ داح ضرم يلأ ةقباس ةيريرس تاملاع مهيدل سيل نيذلا ءاحصلاا نع مجا
دمو هعون صحف ءارجلإ مدلا لصم لصف مت يبطلا ثحبلا زكرم يف .ةيساسحلا فرظو ةلئاعلل ةيريرسلا ةلاحلاو سنجلاو ىضرملا رمعو ضرملا ةARGΙ 
( ميزنلإاب طبترم يعانم ةينقت مادختساب يبصقلا وبرلا عم هتقلاع داجياوELISA طاشن ديدحت مت .)ARGΙ  ايرويلاو نينثروا ىلإ نينيجرلأا ليوحت سايقو
يجوم لوط يلع ةيمكلا ناوللأا سايق سايقم مادختساب490  .رتمونان 
:جئاتنلا  نيب ةيباجيا ةقلاع دوجو يلا جئاتنلا ترهظأARGΙ  نيذلا ىضرملل مدلا لصم يف زينيجرلاا ىوتسم يف ظوحلم عافترا ظحول .يبصقلا وبرلاو
 نع مهرامعا زواجتت81 ةنس و ةميق طسوتم و ةميق p ),)c±19.77100.16; ()0.000( ةباصلاا ةدم عم زينيجرلاا ىوتسم يف ظوحلم ةقلاع ظحول امك .
 نم رثكلأ وبرلاب ةباصملا ىضرملا يف ةيلاع زينيجرلاا ىوتسم ناك ثيح .ضرملاب20 ةنس), c±38.8182.48( و ةميق p )0.01( ةقلاع ظحول كلذك .
تسم يف يونعم ريغ فلاتخا ظحول نكلو .اضيأ ةيساسحلا فرظ عمو ثحتسملا وبرلا عاونأ نم نوناعي نيذلا كئلوأو زينيجرلاا ىوتسم نيب ظوحلم ىو
 .ضيرملا سنجو وبرلا ضرمل ةلئاعلل ةيريرسلا ةلاحلا عم لصملل زينيجرلاا 
 ل ظوحلم طابترا دوجو جئاتنلا ترهظأوARG Ι فوبرلا ضرمريوطت ي يف p  ˂  0.05. 
:جاتنتسلأا  جئاتن تراشأELISA  نأARG I  نم لاع ىوتسم مهيدل وبرلا ضارعأ نم نوناعي نيذلا ىضرملا .يبصقلا وبرلاب ظوحلم لكشب ةطبترم
ARG Ι > 40) .)رتل / ةيلود ةدحو 
 
ةلادلا تاملكلا: زينيجرأ لولأا، وبرلا، L-نينيجرأ، L-نيثينرولأا، .ايرويلا 
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